Related Experiment Videos
A new antitumor antibiotic, chromoxymycin. II. Production, isolation, characterization and antitumor activity
The Journal of Antibiotics
|January 1, 1986
Abstract:
Chromoxymycin is a new antitumor antibiotic produced by a new actinomycete named Streptomyces libani subsp. rubropurpureus No. 6362. Chromoxymycin is active against P388 leukemia and B16 melanoma in mice, and has weak antibacterial activity against some Gram-positive bacteria.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Involvement of N-linked carbohydrate chains of pig zona pellucida in sperm-egg binding.
European journal of biochemistry·1995
[Long-term results of Bentall and modified Bentall procedure in aortic root replacement].
Kyobu geka. The Japanese journal of thoracic surgery·1995
Effects of premotion silent period on single motor unit firing at initiation of a rapid contraction.
Electroencephalography and clinical neurophysiology·1995
[A huge idiopathic brain stone in the posterior fossa].
No shinkei geka. Neurological surgery·1995
CT evaluation of hepatic tumors: comparison of CT with arterial portography, CT with infusion hepatic arteriography, and simultaneous use of both techniques.
AJR. American journal of roentgenology·1995
"Lariocidin and ribosome-targeting lasso peptides as emerging antimicrobial agents against multidrug-resistant bacteria".
The Journal of antibiotics·2026
Two new diastereomeric sterigmatocystin derivatives from the culture broth of Hypomyces sp.
The Journal of antibiotics·2026
AMETHYST: a Retrospective Cohort Study of Treatment Patterns and Outcomes in Patients With Glucocorticoid-refractory Macrophage Activation Syndrome Complicating Still's Disease.
Arthritis & rheumatology (Hoboken, N.J.)·2026
Progress and perspectives in primary mitochondrial myopathy: Highlights from the 2025 mitochondrial medicine masterclass with a focus on TK2 deficiency.
Therapeutic advances in rare disease·2026
Mycobacterial infections and recurrent osteomyelitis in a patient with an autosomal dominant mutation in IFN-gamma receptor 1 with overexpression of the receptor.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026